BioSpace News Archive

Job Trends

Expanded Rubraca® (Rucaparib) Data from Clovis Oncology’s ARIEL3 and TRITON2 Trials in Ovarian and Prostate Cancers to be Presented at 2019 ASCO Annual Meeting

Clovis Oncology, Inc. announced multiple datasets being presented at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago, May 31 – June 4, 2019.

June 1, 2019
·
16 min read
Pharm Country

Five-Year Survival Data for Merck’s KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer (NSCLC) from First KEYNOTE Trial at 2019 ASCO Annual Meeting

Longest Follow-Up Data for KEYTRUDA in Lung Cancer to Date Showed Five-Year Overall Survival Rate of 23.2% with KEYTRUDA in Treatment-Naïve Patients and 15.5% in Previously Treated Patients with Advanced NSCLC in KEYNOTE-001 Trial

June 1, 2019
·
36 min read
Drug Development

Nektar Therapeutics Presents Biomarker and Clinical Data from PIVOT-02 Phase 2 Study of Bempegaldesleukin with Nivolumab at 2019 ASCO Annual Meeting

Nektar Therapeutics announced that biomarker and clinical data from PIVOT-02 is being presented at the 2019 American Society of Clinical Oncology Meeting in Chicago, Illinois.

June 1, 2019
·
7 min read
Drug Development

Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting

Moderna, Inc. announced interim data from an ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumors.

June 1, 2019
·
10 min read
Drug Development

Five Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors at the 2019 ASCO Annual Meeting

Five Prime Therapeutics, Inc. presented monotherapy data from the dose escalation portion of the Phase 1a/1b clinical trial of FPA150 in patients with advanced solid tumors.

June 1, 2019
·
5 min read
Job Trends

Magellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Residents Impacted by the Shooting at the Virginia Beach Municipal Center

Counseling and resources available free-of-charge to local community

June 1, 2019
·
1 min read
Drug Development

IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free Survival

IMV Inc. announced that investigators shared new positive data for its DeCidE1 clinical trial at the 2019 American Society for Clinical Oncology Annual Meeting.

June 1, 2019
·
7 min read
Drug Development

Rakuten Medical Releases Phase 2a Study Data during ASCO Annual Meeting Highlighting Positive Safety Profile and Clinically Meaningful Anti-tumor Activity

Rakuten Medical announces positive data results from its Phase 2a study, evaluating the safety and anti-tumor activity of RM-1929 PIT in patients with locoregional, recurrent head and neck squamous cell carcinoma.

June 1, 2019
·
6 min read
Drug Development

Positive results of lurbinectedin Phase II trial (PharmaMar) for the treatment of relapsed small cell lung cancer are presented at ASCO

The results of PharmaMar’s (MSE: PHM) Phase II study with lurbinectedin as a single agent for the treatment of relapsed small cell lung cancer were presented to the American Society of Clinical Oncology (ASCO) conference, which is currently being held in Chicago.

June 1, 2019
·
5 min read
Business

Patients at St. Joseph’s Children’s Hospital in Tampa Get a Prom of their Very Own

Joseph’s Children’s Hospital hosted prom night for patients who were unable to attend their own dance due to hospitalization or who, due to chronic or life-threatening conditions, may never get the opportunity.

June 1, 2019
·
2 min read